Get startedLog in
    Picture of Astellas Pharma logo

    4503 — Astellas Pharma Cashflow Statement

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Astellas Pharma, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:YuhoYuhoYuhoYuhoYuho
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line145,324156,886132,36124,96931,237
    Depreciation
    Non-Cash Items91,07573,65085,16779,480197,367
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-2,208-52,7774,501-89,813-233,225
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Other Operating Cash Flow
    Cash from Operating Activities306,843257,443327,767172,476194,511
    Capital Expenditures-77,441-76,448-88,541-82,497-57,330
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-4,45314,0354,041-763,305-32,089
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Sale of Intangible Assets
    Other Investing Cash Flow
    Cash from Investing Activities-81,894-62,413-84,500-845,802-89,419
    Financing Cash Flow Items-2,268-2,530-3,217-16,539-23,813
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-229,479-216,298-195,623614,060-261,367
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash7,737-10,14360,854-41,153-147,315